Holmdahl L
Department of Surgery, Ostra Hospital, University of Göteborg, Sweden.
Eur J Surg Suppl. 1997(577):24-31.
Postsurgical abdominal adhesions and their sequelae continue to present major clinical and medicoeconomic problems. A complex network of mediators and responses affecting at least five interrelated biological systems, including the fibrinolytic system, are involved in the pathogenesis of postsurgical adhesions. The fibrinolytic system degrades fibrin through the action of the enzyme plasmin, which is stored as the inactive substrate plasminogen. Fibrinolysis, by mediating fibrin degradation, appears to play a pivotal role in adhesiogenesis. Tissue-type plasminogen activator (tPA) is the chief plasminogen activator in the blood, but its activity is restricted by plasminogen activating inhibitors type 1 (PAI-1) and type 2 (PAI-2). Inadequate peritoneal fibrinolysis may result from decreased tPA, increased PAI-1 and PAI-2, or both. The causal relationship between a reduction in fibrinolytic capacity and the formation of adhesions has been demonstrated in animals. In human studies, plasminogen activator activity (PAA) was significantly reduced in peritoneal biopsies from patients with peritonitis compared with those from normal patients. During surgery, PAA declined significantly in both normal and inflamed peritoneum. tPA was responsible for about 95% of PAA. Reduced fibrinolysis in human peritoneum associated with peritonitis and abdominal surgery correlates with increased adhesion formation and may thus be an important early biochemical event leading to adhesion formation. The regulation of plasmin-mediated fibrin degradation in the peritoneal cavity is poorly understood. However, new insights in the cellular distribution of fibrinolytic components in peritoneal tissue suggest that the mesothelium appears to have a principal role in fibrin regulation in the peritoneal cavity and in the early formation of adhesions.
术后腹腔粘连及其后遗症仍然是主要的临床和医学经济问题。一个复杂的介质和反应网络,涉及至少五个相互关联的生物系统,包括纤维蛋白溶解系统,参与了术后粘连的发病机制。纤维蛋白溶解系统通过酶纤溶酶的作用降解纤维蛋白,纤溶酶以无活性的底物纤溶酶原形式储存。通过介导纤维蛋白降解,纤维蛋白溶解似乎在粘连形成中起关键作用。组织型纤溶酶原激活剂(tPA)是血液中主要的纤溶酶原激活剂,但其活性受到1型纤溶酶原激活抑制剂(PAI-1)和2型纤溶酶原激活抑制剂(PAI-2)的限制。腹膜纤维蛋白溶解不足可能是由于tPA减少、PAI-1和PAI-2增加,或两者兼而有之。纤维蛋白溶解能力降低与粘连形成之间的因果关系已在动物实验中得到证实。在人体研究中,与正常患者相比,腹膜炎患者腹膜活检中的纤溶酶原激活剂活性(PAA)显著降低。手术期间,正常腹膜和发炎腹膜中的PAA均显著下降。tPA约占PAA的95%。与腹膜炎和腹部手术相关的人体腹膜纤维蛋白溶解减少与粘连形成增加相关,因此可能是导致粘连形成的重要早期生化事件。目前对腹腔内纤溶酶介导的纤维蛋白降解的调节了解甚少。然而,对腹膜组织中纤维蛋白溶解成分细胞分布的新见解表明,间皮似乎在腹腔内纤维蛋白调节和粘连早期形成中起主要作用。